S17 Hormones and Stem Cells in Development and Disease

Program: Symposia
Basic Session
Friday, April 1, 2016: 4:45 PM-6:15 PM
Room 104 (BCEC)
Carol Ann Sartorius, PhD, University of Colorado Denver Anschutz Medical Campus, Aurora, CO

Nothing to Disclose: CAS
4:45 PM
Gail S. Prins, PhD, Dept of Urology, University of Illinois-Chicago, Chicago, IL
Nothing to Disclose: GSP
5:15 PM
Tan A Ince, MD, PhD, Pathology, University of Miami Miller School of Medicine, Miami, FL
Nothing to Disclose: TAI
5:45 PM
Michelina Plateroti, Cancer Cell Plasticity, Centre de Recherche en Cancérologie de Lyon, Lyon, France
Nothing to Disclose: MP
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire